Summary
Thuraxe has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €200,688 and a net result of €33,759. Equity is growing by about 20% per year across the filed financial years. Its solvency ranks better than 44% of 2,778 sector peers (NACE 82, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
24-01
Gazette deed
Appointments: Lein Terryn (statutory director) and TERRYN Glenn Marc (statutory director)Board rule · Amendment of the articles · Power of attorney9 facts ▸
- General meeting, “buitengewone algemene vergadering” (deed in Dutch)
- Other provision, 19-01-2024
- Director appointment, Lein Terryn (statutory director)
- Other provision, “beroepsverbod, geen beroepsverbod lopende” (deed in Dutch) (2 times)
- Director appointment, TERRYN Glenn Marc (statutory director)
- Board rule, “enige bestuurder”, 1 (deed in Dutch)
- Amendment of the articles
- Power of attorney
- Power of attorney, Annelies HIMPE
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.